ÀºÇòÅâÂÊ

ÀºÇòÅâÂÊ Services FAQ Contact Us 0
Home Pharmaceuticals North America Pharmacogenomics Market Size, Trend, Analysis, and Forecast 2030
North America Pharmacogenomics Market
Select Regional / Country Report
Global Europe North America

North America Pharmacogenomics Market Size, Share & Trends Analysis Report By Technology (PCR, Sequencing, Microarray, Gel electrophoresis, Mass Spectrometry, Other technologies), By Application (Drug discovery, Cancer, Neurology and psychiatry, Pain management, Cardiovascular disorders, Others), By End-User (Hospitals and clinics, Biopharmaceutical firms, CROs and CDMOs, Others) and By Country(US, Canada) Forecasts, 2024-2032

Report Code: SRPH3308DR
Author : ÀºÇòÅâÂÊ
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
  2. ESG Trends
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Products
        1. By Value
        2. Genotyping Kits
          1. Genotyping Kits By Value
        3. Sequencing Instruments
          1. Sequencing Instruments By Value
        4. PCR Reagents and Consumables
          1. PCR Reagents and Consumables By Value
        5. Sample Preparation Kits
          1. Sample Preparation Kits By Value
        6. Others
          1. Others By Value
      3. Services
        1. By Value
        2. Genetic Testing Services
          1. Genetic Testing Services By Value
        3. Pharmacogenomic Consulting
          1. Pharmacogenomic Consulting By Value
        4. Others
          1. Others By Value
      4. Software
        1. By Value
        2. Bioinformatics Software
          1. Bioinformatics Software By Value
        3. Clinical Decision Support System
          1. Clinical Decision Support System By Value
        4. Laboratory Information Management System
          1. Laboratory Information Management System By Value
        5. EHR Integration Software
          1. EHR Integration Software By Value
        6. Others
          1. Others By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Next-Generation Sequencing
        1. By Value
      3. Polymerase Chain Reaction
        1. By Value
      4. Mass Spectrometry
        1. By Value
      5. Microarray
        1. By Value
      6. Others
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Cardiovascular disease
        1. By Value
      3. Infectious diseases
        1. By Value
      4. Oncology
        1. By Value
      5. Neurological diseases
        1. By Value
      6. Pain Management and Trauma
        1. By Value
      7. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Clinical Laboratories
        1. By Value
      4. Pharmaceutical Companies
        1. By Value
      5. Academic Research Institutions
        1. By Value
      6. Others
        1. By Value
    6. US
      1. By Type
        1. Introduction
          1. Type By Value
        2. Products
          1. By Value
          2. Genotyping Kits
            1. Genotyping Kits By Value
          3. Sequencing Instruments
            1. Sequencing Instruments By Value
          4. PCR Reagents and Consumables
            1. PCR Reagents and Consumables By Value
          5. Sample Preparation Kits
            1. Sample Preparation Kits By Value
          6. Others
            1. Others By Value
        3. Services
          1. By Value
          2. Genetic Testing Services
            1. Genetic Testing Services By Value
          3. Pharmacogenomic Consulting
            1. Pharmacogenomic Consulting By Value
          4. Others
            1. Others By Value
        4. Software
          1. By Value
          2. Bioinformatics Software
            1. Bioinformatics Software By Value
          3. Clinical Decision Support System
            1. Clinical Decision Support System By Value
          4. Laboratory Information Management System
            1. Laboratory Information Management System By Value
          5. EHR Integration Software
            1. EHR Integration Software By Value
          6. Others
            1. Others By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Next-Generation Sequencing
          1. By Value
        3. Polymerase Chain Reaction
          1. By Value
        4. Mass Spectrometry
          1. By Value
        5. Microarray
          1. By Value
        6. Others
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Cardiovascular disease
          1. By Value
        3. Infectious diseases
          1. By Value
        4. Oncology
          1. By Value
        5. Neurological diseases
          1. By Value
        6. Pain Management and Trauma
          1. By Value
        7. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Clinical Laboratories
          1. By Value
        4. Pharmaceutical Companies
          1. By Value
        5. Academic Research Institutions
          1. By Value
        6. Others
          1. By Value
    7. Canada
    1. North America Pharmacogenomics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Admera Health
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Abbott Laboratories
    3. Agilent Technologies
    4. Novartis AG
    5. Dynamic DNA Laboratories
    6. Empire Genomics, LLC.
    7. Hoffmann-La Roche Ltd.
    8. Illumina, Inc.
    9. OneOme, LLC
    10. Myriad Genetics Inc.
    11. OPKO Health, Inc. (GeneDx.)
    12. Thermo Fisher Scientific, Inc.
    13. AltheaDx
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The global pharmacogenomics services market size was valued at USD 5.10 billion in 2021. It is projected to reach USD 8.84 billion by 2030, growing at a CAGR of 5.65% during the forecast period (2022–2030). Factors such as increasing preva
Buy Now
Global Report
The global proteomics market size was valued at USD 34.69 billion in 2023. It is estimated to reach USD 80.50 billion by 2032, growing at a CAGR of 12.30% during the forecast period (2024–2032). The surge in pharmaceutical and biotechnology com
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

ÀºÇòÅâÂÊ
© Copyright . All rights Reserved.